CT
Curamir Therapeutics develops miRNA-based therapeutics targeting cancer by utilizing microRNA modulation to inhibit tumor growth and metastasis. This approach aims to improve treatment efficacy and reduce side effects compared to traditional therapies.
Updated 20 months ago
Funding
$10M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Curamir Therapeutics develops miRNA-based therapeutics targeting cancer by utilizing microRNA modulation to inhibit tumor growth and metastasis. This approach aims to improve treatment efficacy and reduce side effects compared to traditional therapies.